Latest Commercialisation News

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Triangle Energy and Athena Exploration have significantly upgraded gas resource estimates for the UK P2628 permit, positioning themselves among the top undeveloped gas holders in the region.

Botala Energy has raised A$1.5 million through a discounted share placement to fund critical drilling and feasibility work at its Serowe CBM Project in Botswana. Directors and the CEO are backing the raise, signaling confidence in the project’s potential.

AML3D Limited reported a modest increase in revenue for FY2025 but saw its losses widen significantly, raising questions about its path to profitability.

Silex Systems Limited has announced a Share Purchase Plan (SPP) aiming to raise up to $15 million, offering existing eligible shareholders new shares at a price capped at $3.90 or a 2% discount to recent trading prices. This follows a $130 million institutional placement and supports key commercialisation projects in uranium enrichment.

dorsaVi Ltd has raised A$5 million through a strategic placement to accelerate development of its next-generation RRAM-enabled sensors and robotics platforms, signaling a bold expansion into edge AI and neuromorphic computing.

HyTerra Limited’s McCoy 1 well in Kansas has confirmed significant concentrations of geologic hydrogen and helium, advancing the company’s exploration ambitions with appraisal activities now underway.

HITIQ Limited has successfully closed its shortfall offer, raising a total of $2.16 million through a combination of a rights issue and placement, while continuing discussions to secure additional funding.

EMVision Medical Devices has been awarded a $3 million non-dilutive government grant to conduct a pioneering clinical study using its telehealth-enabled emu™ brain scanner in regional South Australia, aiming to transform stroke diagnosis and treatment.

AnteoTech has mutually terminated its A$1.4 million Queensland government grant to avoid costly co-investment, opting instead for cheaper third-party testing to advance its Ultranode™ battery technology.

Carnegie Clean Energy launches a $3 million Share Purchase Plan to fuel commercialisation of its wave and MoorPower technologies, capitalising on growing global momentum in ocean energy.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.